fbpx

Angle PLC

AGLE.L

$0.12

Closing

▼-2.56%

1D

▼-19.02%

YTD

AGLE

BBG001SJWTQ8

Exchange

Sector

Market cap

$39.07M

Volume

1,274,417

Check if the stock is halal

Unlock Industry-grade Shariah Compliance for global stocks. See results from 5 major Shariah standards: AAOIFI, S&P, DJIM, FTSE and MSCI.

We provide unparalleled value and service.
Screened by AAOIFI Certified Shariah Advisor & Auditor.

Get started from just $6.99/month

Market cap

$39.07M

Analysts' Rating

BUY

Price Target (Mean)

0.89

Total Analysts

0

P/E

Operating Margin

-803.00%

Beta

0.98

Revenue Growth

-13.55%

52 week high

$0.47

52 week low

$0.09

Div. Yield

%

EPS Growth

0.00

Company Profile

ANGLE plc is a United Kingdom-based liquid biopsy company with circulating tumor cell (CTC) solutions for use in research, drug development and clinical oncology using a simple blood sample. Its circulating tumor cell (CTC) harvesting technology known as the Parsortix PC1 System enables complete downstream analysis of the sample, including whole cell imaging and proteomic analysis and full genomic and transcriptomic molecular analysis. The Parsortix PC1 system is a medical device for the capture and harvest of intact CTCs from metastatic breast cancer (MBC) patient blood for user-validated analysis. Its commercial businesses focus on diagnostic products and clinical services. Its diagnostic products include the Parsortix system and associated consumables. Its services include custom made assay development and clinical trial testing for pharma. The Parsortix technology uses a microfluidic technology in the form of a single use cassette to capture and then harvest CTCs from whole blood.